Vibrational spectroscopic analysis of hydroxyapatite in HYP mice and individuals with X-linked hypophosphatemia. 2018

Eva Amenta, and Helen E King, and Holger Petermann, and Vuk Uskoković, and Steven M Tommasini, and Carolyn M Macica
Department of Medical Sciences, Frank H. Netter, M.D., School of Medicine at Quinnipiac University, North Haven, CT, USA.

BACKGROUND X-linked hypophosphatemia (XLH) is the most common form of familial phosphate-wasting disorders, due to an inactivating mutation in the phosphate-regulating neutral endopeptidase, X-linked gene. Persistent osteomalacia, enthesophytes, osteophytes, degenerative arthritis and dental abscesses/periodontal disease dominate the adult disorder. However, the impact of insufficient phosphate on hydroxyapatite composition, the major inorganic component of bone and teeth, is unknown in individuals with XLH. METHODS Using Raman spectroscopy, the carbonate (CO3 2-) to phosphate (PO4 3-) ion ratio was measured in HYP and wild-type mice and in primary and permanent teeth from XLH individuals and unaffected controls. RESULTS There was a significant difference in carbonate ion substitution between the HYP and wild-type femoral cortical bone (0.36 ± 0.08 versus 0.24 ± 0.04; p < 0.001). Carbonate ion substitution levels were also higher in permanent XLH teeth compared with unaffected individuals (0.39 ± 0.12 versus 0.23 ± 0.04; p < 0.001), but not in primary teeth (0.29 ± 0.11 versus 0.26 ± 0.02; p = 0.29). Complementary Fourier transform infrared analyses demonstrated higher relative intensities of the four major vibrational bands originating from the carbonate anion in XLH teeth compared with unaffected controls. CONCLUSIONS Ionic substitution within the crystal lattice is a common feature of hydroxyapatite and one that confers the physiological properties of bone that impact mechanical strength and the process of bone remodeling. Our data demonstrating anionic substitution in human dentin from individuals with XLH validate the use of dentin as a proxy for bone and to better understand the molecular adaptations that occur in the biochemical milieu of XLH.

UI MeSH Term Description Entries

Related Publications

Eva Amenta, and Helen E King, and Holger Petermann, and Vuk Uskoković, and Steven M Tommasini, and Carolyn M Macica
February 1985, The American journal of pathology,
Eva Amenta, and Helen E King, and Holger Petermann, and Vuk Uskoković, and Steven M Tommasini, and Carolyn M Macica
September 2009, Calcified tissue international,
Eva Amenta, and Helen E King, and Holger Petermann, and Vuk Uskoković, and Steven M Tommasini, and Carolyn M Macica
February 1997, Human molecular genetics,
Eva Amenta, and Helen E King, and Holger Petermann, and Vuk Uskoković, and Steven M Tommasini, and Carolyn M Macica
April 2020, Journal of dental research,
Eva Amenta, and Helen E King, and Holger Petermann, and Vuk Uskoković, and Steven M Tommasini, and Carolyn M Macica
June 1979, Canadian journal of biochemistry,
Eva Amenta, and Helen E King, and Holger Petermann, and Vuk Uskoković, and Steven M Tommasini, and Carolyn M Macica
January 2001, Ryoikibetsu shokogun shirizu,
Eva Amenta, and Helen E King, and Holger Petermann, and Vuk Uskoković, and Steven M Tommasini, and Carolyn M Macica
January 2021, Frontiers in pediatrics,
Eva Amenta, and Helen E King, and Holger Petermann, and Vuk Uskoković, and Steven M Tommasini, and Carolyn M Macica
March 1989, Seminars in nephrology,
Eva Amenta, and Helen E King, and Holger Petermann, and Vuk Uskoković, and Steven M Tommasini, and Carolyn M Macica
October 2017, Bone,
Eva Amenta, and Helen E King, and Holger Petermann, and Vuk Uskoković, and Steven M Tommasini, and Carolyn M Macica
August 2017, BMJ case reports,
Copied contents to your clipboard!